Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Factor VIII in Severe Hemophilia A
CTR20192707Phase 3Completed
- Sponsor
- Chengdu Rongsheng Pharmaceutical
- Start
- Jan 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human coagulation factor VIII in hemophilia A, sponsored by Chengdu Rongsheng Pharmaceutical. Started Jan 2020; status: completed.
02
Drugs
recombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on CTR20192707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192707.